Portfolio company
NeuroTronik
United States · £18.2m raised
Raised
£18.2m
Latest stage
Series B
Rounds recorded
2 · 1 undisclosed
Backed by
1 investor
Sectors
About
This medical technology company develops neurostimulation systems for clinicians to treat patients suffering from acute heart failure.
SourceFunding history · 2
Similar companies
CVRx
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
Nervonik
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems for patients suffering from chronic neuropathic pain.
Ceryx Medical
This company develops bioelectronic medical devices and pacing technology to treat patients with heart failure, hypertension and neurological injuries.
Levron
This company develops a cardio-respiratory physiological assist device that synchronises heart rhythm with respiratory dynamics for patients with chronic heart failure.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
BioVentrix®
This medical device company develops minimally invasive therapies for cardiothoracic surgeons to treat heart failure by restoring the shape of the left ventricle.
